The clinical relevance of tumor RAS/TP53 dual mutation in early and metastatic colorectal cancer (CRC).
Seligmann JF., Domingo E., Fisher D., Elliott F., Brown LC., Seymour MT., Richman S., Quirke P., Butler R., Roberts H., Camps C., Kaisaki P., Church DN., Kerr DJ., Kerr R., Wilson RH., Sieber O., Taylor J., Tomlinson I., Maughan T.